Integration of troponin i phosphorylation with cardiac regulatory networks

Circulation Research

Volumn 112, Issue 2, 2013, Pages 355-366

  Solaro, R John ^a   Henze, Marcus ^a   Kobayashi, Tomoyoshi ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Ca sensitization; Ca signaling; cardiac hypertrophy; ventricular myocytes . Z disk

Indexed keywords

CALCIUM; SERINE; TROPONIN I;

CALCIUM TRANSPORT; DISEASE COURSE; HEART; HEART BEAT; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE METABOLISM; HOMEOSTASIS; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SARCOMERE; SIGNAL TRANSDUCTION; THIN FILAMENT;

ANIMALS; CARDIOMEGALY; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; HUMANS; MYOCYTES, CARDIAC; PHOSPHORYLATION; TROPONIN I;

EID: 84872875468     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.268672     Document Type: Review

References (123)

1. Solaro RJ. Sarcomere control mechanisms and the dynamics of the cardiac cycle. J Biomed Biotechnol. 2010;2010:105648.
2. Solaro RJ, Kobayashi T. Protein phosphorylation and signal transduction in cardiac thin filaments. J Biol Chem. 2011;286:9935-9940.
3. Solaro RJ, van der Velden J. Why does troponin I have so many phosphorylation sites? Fact and fancy. J Mol Cell Cardiol. 2010;48:810-816.
4. Metzger JM, Westfall MV. Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ Res. 2004;94:146-158.
5. Pyle WG, Solaro RJ. At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function. Circ Res. 2004;94:296-305.
6. Hoshijima M. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am J Physiol Heart Circ Physiol. 2006;290:H1313-H1325.
7. Solaro RJ. Remote control of A-band cardiac thin filaments by the I-Z-I protein network of cardiac sarcomeres. Trends Cardiovasc Med. 2005;15:148-152.
8. Wolska BM, Wieczorek DM. The role of tropomyosin in the regulation of myocardial contraction and relaxation. Pflugers Arch. 2003;446:1-8.
9. Hitchcock-DeGregori SE, Greenfield NJ, Singh A. Tropomyosin: regulator of actin filaments. Adv Exp Med Biol. 2007;592:87-97.
10. Li XE, Tobacman LS, Mun JY, Craig R, Fischer S, Lehman W. Tropomyosin position on F-actin revealed by EM reconstruction and computational chemistry. Biophys J. 2011;100:1005-1013.
11. Kowlessur D, Tobacman LS. Troponin regulatory function and dynamics revealed by H/D exchange-mass spectrometry. J Biol Chem. 2010;285:2686-2694.
12. Brown JH, Kim KH, Jun G, Greenfield NJ, Dominguez R, Volkmann N, Hitchcock-DeGregori SE, Cohen C. Deciphering the design of the tropomyosin molecule. Proc Natl Acad Sci USA. 2001;98:8496-8501.
13. Sumida JP, Wu E, Lehrer SS. Conserved Asp-137 imparts flexibility to tropomyosin and affects function. J Biol Chem. 2008;283:6728-6734.
14. Li XE, Suphamungmee W, Janco M, Geeves MA, Marston SB, Fischer S, Lehman W. The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 2012;424:493-496.
15. Ly S, Lehrer SS. Long-range effects of familial hypertrophic cardiomyopathy mutations E180G and D175N on the properties of tropomyosin. Biochemistry. 2012;51:6413-6420.
16. Sun YB, Irving M. The molecular basis of the steep force-calcium relation in heart muscle. J Mol Cell Cardiol. 2010;48:859-865.
17. Pan BS, Gordon AM, Luo ZX. Removal of tropomyosin overlap modifies cooperative binding of myosin S-1 to reconstituted thin filaments of rabbit striated muscle. J Biol Chem. 1989;264:8495-8498.
18. Kobayashi T, Solaro RJ. Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu Rev Physiol. 2005;67:39-67.
19. Gali?ska-Rakoczy A, Engel P, Xu C, Jung H, Craig R, Tobacman LS, Lehman W. Structural basis for the regulation of muscle contraction by troponin and tropomyosin. J Mol Biol. 2008;379:929-935.
20. +-dependent photocrosslinking of tropomyosin residue 146 to residues 157-163 in the C-terminal domain of troponin I in reconstituted skeletal muscle thin filaments. J Mol Biol. 2009;389:575-583.
21. Holroyde MJ, Robertson SP, Johnson JD, Solaro RJ, Potter JD. The calcium and magnesium binding sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J Biol Chem. 1980;255:11688-11693.
22. Baryshnikova OK, Li MX, Sykes BD. Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: influence of PKA phosphorylation and involvement in cardiomyopathies. J Mol Biol. 2008;375:735-751.
23. +-modulated allosteric domain in the troponin complex. Biochemistry. 2001;40:2623-2631.
24. Tachampa K, Kobayashi T, Wang H, Martin AF, Biesiadecki BJ, Solaro RJ, de Tombe PP. Increased cross-bridge cycling kinetics after exchange of C-terminal truncated troponin I in skinned rat cardiac muscle. J Biol Chem. 2008;283:15114-15121.
25. Takeda S, Kobayashi T, Taniguchi H, Hayashi H, Maéda Y. Structural and functional domains of the troponin complex revealed by limited digestion. Eur J Biochem. 1997;246:611-617.
26. Bremel RD, Weber A. Cooperation within actin filament in vertebrate skeletal muscle. Nature New Biol. 1972;238:97-101.
27. Fitzsimons DP, Moss RL. Cooperativity in the regulation of force and the kinetics of force development in heart and skeletal muscles: cross-bridge activation of force. Adv Exp Med Biol. 2007;592:177-189.
28. Moss RL, Fitzsimons DP. Regulation of contraction in mammalian striated muscles-the plot thick-ens. J Gen Physiol. 2010;136:21-27.
29. Tobacman LS, Sawyer D. Calcium binds cooperatively to the regulatory sites of the cardiac thin filament. J Biol Chem. 1990;265:931-939.
30. Mehegan JP, Tobacman LS. Cooperative interactions between troponin molecules bound to the cardiac thin filament. J Biol Chem. 1991;266:966-972.
31. Davis JP, Norman C, Kobayashi T, Solaro RJ, Swartz DR, Tikunova SB. Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C. Biophys J. 2007;92:3195-3206.
32. Sun YB, Lou F, Irving M. Calcium-and myosin-dependent changes in troponin structure during activation of heart muscle. J Physiol (Lond). 2009;587:155-163.
33. Farman GP, Allen EJ, Schoenfelt KQ, Backx PH, de Tombe PP. The role of thin filament cooperativity in cardiac length-dependent calcium activation. Biophys J. 2010;99:2978-2986.
34. de Tombe PP, Mateja RD, Tachampa K, Ait Mou Y, Farman GP, Irving TC. Myofilament length dependent activation. J Mol Cell Cardiol. 2010;48:851-858.
35. +-regulatory site of bovine cardiac troponin. J Biol Chem. 1982;257:260-263.
36. Konhilas JP, Irving TC, Wolska BM, Jweied EE, Martin AF, Solaro RJ, de Tombe PP. Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing. J Physiol (Lond). 2003;547:951-961.
37. Arteaga GM, Palmiter KA, Leiden JM, Solaro RJ. Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I. J Physiol (Lond). 2000;526(pt 3):541-549.
38. Engel PL, Kobayashi T, Biesiadecki B, Davis J, Tikunova S, Wu S, Solaro RJ. Identification of a region of troponin I important in signaling cross-bridge-dependent activation of cardiac myofilaments. J Biol Chem. 2007;282:183-193.
39. Kobayashi T, Patrick SE, Kobayashi M. Ala scanning of the inhibitory region of cardiac troponin I. J Biol Chem. 2009;284:20052-20060.
40. Chandra M, Tschirgi ML, Rajapakse I, Campbell KB. Troponin T modulates sarcomere length-dependent recruitment of cross-bridges in cardiac muscle. Biophys J. 2006;90:2867-2876.
41. Hinken AC, Solaro RJ. A dominant role of cardiac molecular motors in the intrinsic regulation of ventricular ejection and relaxation. Physiology (Bethesda). 2007;22:73-80.
42. Solaro RJ, Wise RM, Shiner JS, Briggs FN. Calcium requirements for cardiac myofibrillar activation. Circ Res. 1974;34:525-530.
43. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol. 2008;70:23-49.
44. Kass DA, Solaro RJ. Mechanisms and use of calcium-sensitizing agents in the failing heart. Circulation. 2006;113:305-315.
45. Malik FI, Hartman JJ, Elias KA, et al. Cardiac myosin activation: a potential therapeutic approach for systolic heart failure. Science. 2011;331:1439-1443.
46. Scruggs SB, Hinken AC, Thawornkaiwong A, Robbins J, Walker LA, de Tombe PP, Geenen DL, Buttrick PM, Solaro RJ. Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation. J Biol Chem. 2009;284:5097-5106.
47. Kirk JA, MacGowan GA, Evans C, Smith SH, Warren CM, Mamidi R, Chandra M, Stewart AF, Solaro RJ, Shroff SG. Left ventricular and myocardial function in mice expressing constitutively pseudophosphorylated cardiac troponin I. Circ Res. 2009;105:1232-1239.
48. Lovelock JD, Monasky MM, Jeong EM, Lardin HA, Liu H, Patel BG, Taglieri DM, Gu L, Kumar P, Pokhrel N, Zeng D, Belardinelli L, Sorescu D, Solaro RJ, Dudley SC Jr. Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity. Circ Res. 2012;110:841-850.
49. + fluxes. J Mol Cell Cardiol. 2010;48:834-842.
50. + sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest. 2008;118:3893-3903.
51. Solaro RJ. Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins. J Biol Chem. 2008;283:26829-26833.
52. Mamidi R, Gollapudi SK, Mallampalli SL, Chandra M. Alanine or aspartic acid substitutions at serine23/24 of cardiac troponin I decrease thin filament activation, with no effect on crossbridge detachment kinetics. Arch Biochem Biophys. 2012;525:1-8.
53. Walker JS, Walker LA, Margulies K, Buttrick P, de Tombe P. Protein kinase A changes calcium sensitivity but not crossbridge kinetics in human cardiac myofibrils. Am J Physiol Heart Circ Physiol. 2011;301:H138-H146.
54. Biesiadecki BJ, Kobayashi T, Walker JS, Solaro RJ, de Tombe PP. The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation. Circ Res. 2007;100:1486-1493.
55. Hinken AC, Hanft LM, Scruggs SB, Sadayappan S, Robbins J, Solaro RJ, McDonald KS. Protein kinase C depresses cardiac myocyte power output and attenuates myofilament responses induced by protein kinase A. J Muscle Res Cell Motil. 2012;33:439-448.
56. Takimoto E, Soergel DG, Janssen PM, Stull LB, Kass DA, Murphy AM. Frequency-and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites. Circ Res. 2004;94:496-504.
57. +)-saturated form. Nature. 2003;424:35-41.
58. Howarth JW, Meller J, Solaro RJ, Trewhella J, Rosevear PR. Phosphorylation-dependent conformational transition of the cardiac specific N-extension of troponin I in cardiac troponin. J Mol Biol. 2007;373:706-722.
59. Schmidtmann A, Lindow C, Villard S, Heuser A, Mügge A, Gessner R, Granier C, Jaquet K. Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C. FEBS J. 2005;272:6087-6097.
60. Warren CM, Kobayashi T, Solaro RJ. Sites of intra-and intermolecular cross-linking of the N-terminal extension of troponin I in human cardiac whole troponin complex. J Biol Chem. 2009;284:14258-14266.
61. Gomes AV, Potter JD. Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene. Mol Cell Biochem. 2004;263:99-114.
62. Deng Y, Schmidtmann A, Redlich A, Westerdorf B, Jaquet K, Thieleczek R. Effects of phosphorylation and mutation R145G on human cardiac troponin I function. Biochemistry. 2001;40:14593-14602.
63. +)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem. 1995;270:25445-25454.
64. Goldspink PH, Montgomery DE, Walker LA, Urboniene D, McKinney RD, Geenen DL, Solaro RJ, Buttrick PM. Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res. 2004;95:424-432.
65. Roman BB, Goldspink PH, Spaite E, Urboniene D, McKinney R, Geenen DL, Solaro RJ, Buttrick PM. Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo. Am J Physiol Heart Circ Physiol. 2004;286:H2089-H2095.
66. Scruggs SB, Walker LA, Lyu T, Geenen DL, Solaro RJ, Buttrick PM, Goldspink PH. Partial replacement of cardiac troponin I with a nonphosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation. J Mol Cell Cardiol. 2006;40:465-473.
67. Burkart EM, Sumandea MP, Kobayashi T, Nili M, Martin AF, Homsher E, Solaro RJ. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem. 2003;278:11265-11272.
68. Sakthivel S, Finley NL, Rosevear PR, Lorenz JN, Gulick J, Kim S, VanBuren P, Martin LA, Robbins J. In vivo and in vitro analysis of cardiac troponin I phosphorylation. J Biol Chem. 2005;280:703-714.
69. Belin RJ, Sumandea MP, Kobayashi T, Walker LA, Rundell VL, Urboniene D, Yuzhakova M, Ruch SH, Geenen DL, Solaro RJ, de Tombe PP. Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. Am J Physiol Heart Circ Physiol. 2006;291:H2344-H2353.
70. Belin RJ, Sumandea MP, Allen EJ, Schoenfelt K, Wang H, Solaro RJ, de Tombe PP. Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res. 2007;101:195-204.
71. +-sensitive isoforms in the failing human heart. Circulation. 1999;99:384-391.
72. Takeishi Y, Chu G, Kirkpatrick DM, Li Z, Wakasaki H, Kranias EG, King GL, Walsh RA. In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest. 1998;102:72-78.
73. Hwang H, Robinson DA, Stevenson TK, Wu HC, Kampert SE, Pagani FD, Dyke DB, Martin JL, Sadayappan S, Day SM, Westfall MV. PKCβII modulation of myocyte contractile performance. J Mol Cell Cardiol. 2012;53:176-186.
74. Dong X, Sumandea CA, Chen YC, Garcia-Cazarin ML, Zhang J, Balke CW, Sumandea MP, Ge Y. Augmented phosphorylation of cardiac troponin I in hypertensive heart failure. J Biol Chem. 2012;287:848-857.
75. Zhang P, Kirk JA, Ji W, dos Remedios CG, Kass DA, Van Eyk JE, Murphy AM. Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart. Circulation. 2012;126:1828-1837.
76. Henze M, Patrick SE, Hinken AC, Scruggs SB, Goldspink PH, de Tombe PP, Kobayashi M, Ping P, Kobayashi T, Solaro RJ. New insights into the functional significance of the acidic region of the unique n-terminal extension of cardiac troponin I. Biochimica et Biophysica Acta Mol Cell Res. 2012
77. Howarth JW, Ramisetti S, Nolan K, Sadayappan S, Rosevear PR. Structural insight into the unique cardiac myosin binding protein-c motif: A partially folded domain. J Biol Chem. 2012;373:706-722.
78. Sadayappan S, Finley N, Howarth JW, Osinska H, Klevitsky R, Lorenz JN, Rosevear PR, Robbins J. Role of the acidic N' region of cardiac troponin I in regulating myocardial function. FASEB J. 2008;22: 1246-1257.
79. Murphy RT, Mogensen J, Shaw A, Kubo T, Hughes S, McKenna WJ. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet. 2004;363:371-372.
80. You B, Yan G, Zhang Z, Yan L, Li J, Ge Q, Jin JP, Sun J. Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase 1. Biochem J. 2009;418:93-101.
81. Sumandea MP, Rybin VO, Hinken AC, Wang C, Kobayashi T, Harleton E, Sievert G, Balke CW, Feinmark SJ, Solaro RJ, Steinberg SF. Tyrosine phosphorylation modifies protein kinase C delta-dependent phosphorylation of cardiac troponin I. J Biol Chem. 2008;283:22680-22689.
82. Sumandea MP, Steinberg SF. Redox signaling and cardiac sarcomeres. J Biol Chem. 2011;286:9921-9927.
83. Abbott MB, Gaponenko V, Abusamhadneh E, Finley N, Li G, Dvoretsky A, Rance M, Solaro RJ, Rosevear PR. Regulatory domain conformational exchange and linker region flexibility in cardiac troponin C bound to cardiac troponin I. J Biol Chem. 2000;275:20610-20617.
84. Avner BS, Hinken AC, Yuan C, Solaro RJ. H2O2 alters rat cardiac sarcomere function and protein phosphorylation through redox signaling. Am J Physiol Heart Circ Physiol. 2010;299:H723-H730.
85. Frank D, Frey N. Cardiac Z-disc signaling network. J Biol Chem. 2011;286:9897-9904.
86. Ke Y, Wang L, Pyle WG, de Tombe PP, Solaro RJ. Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes. Circ Res. 2004;94:194-200.
87. + flux modification with altered regulatory protein phosphorylation in cardiac myocytes. Am J Physiol, Cell Physiol. 2009;296:C47-C58.
88. Liu W, Zi M, Naumann R, et al. Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation. 2011;124:2702-2715.
89. Hartman TJ, Martin JL, Solaro RJ, Samarel AM, Russell B. CapZ dynamics are altered by endothelin-1 and phenylephrine via PIP2-and PKC-dependent mechanisms. Am J Physiol, Cell Physiol. 2009;296:C1034-C1039.
90. Pyle WG, Hart MC, Cooper JA, Sumandea MP, de Tombe PP, Solaro RJ. Actin capping protein: an essential element in protein kinase signaling to the myofilaments. Circ Res. 2002;90:1299-1306.
91. Pyle WG, La Rotta G, de Tombe PP, Sumandea MP, Solaro RJ. Control of cardiac myofilament activation and PKC-betaII signaling through the actin capping protein, CapZ. J Mol Cell Cardiol. 2006;41:537-543.
92. Yang FH, Pyle WG. Cardiac actin capping protein reduction and protein kinase C inhibition maintain myofilament function during cardioplegic arrest. Cell Physiol Biochem. 2011;27:263-272.
93. Yang FH, Pyle WG. Reduced cardiac CapZ protein protects hearts against acute ischemia-reperfusion injury and enhances preconditioning. J Mol Cell Cardiol. 2012;52:761-772.
94. Littlefield R, Almenar-Queralt A, Fowler VM. Actin dynamics at pointed ends regulates thin filament length in striated muscle. Nat Cell Biol. 2001;3:544-551.
95. Sussman MA, Welch S, Cambon N, Klevitsky R, Hewett TE, Price R, Witt SA, Kimbrall TR. Myofibril degeneration caused by tropomodulin overexperession leads to dilated cardiomyopathy in juvenile mice. J Clin Invest. 1998;101:51-61.
96. Kostyukova AS, Choy A, Rapp BA. Tropomodulin binds two tropomyosins: a novel model for actin filament capping. Biochemistry. 2006;45:12068-12075.
97. Eyers CE, McNeill H, Knebel A, Morrice N, Arthur SJ, Cuenda A, Cohen P. The phosphorylation of CapZ-interacting protein (CapZIP) by stress-activated protein kinases triggers its dissociation from CapZ. Biochem J. 2005;389:127-135.
98. Hernandez-Valladares M, Kim T, Kannan B, Tung A, Aguda AH, Larsson M, Cooper JA, Robinson RC. Structural characterization of a capping protein interaction motif defines a family of actin filament regulators. Nat Struct Mol Biol. 2010;17:497-503.
99. Kotlo K, Johnson KR, Grillon JM, Greenen DL, Detombe P, Danzigar RS. Phosphoprotein abundance changes in hypertensive cardiac remodeling. J Proteomics. 2012;77:1-3.
100. Kan OM, Takeya R, Taniguchi K, Tanoue Y, Tominaga R, Sumimoto H. Expression and subcellular localization of mammalian formin Fhod3 in the embryonic and adult heart. PLoS One. 2012;7:e34765.
101. Iskratsch T, Lange S, Dwyer J, Kho AL, dos Remedios C, Ehler E. Formin follows function: a muscle-specific isoform of FHOD3 is regulated by CK2 phosphorylation and promotes myofibril maintenance. J Cell Biol. 2010:191:1159-1172.
102. Su H, Wang X. p62 stages an interplay between the ubiquitin-proteasome system and authophagy in the heart of defense against proteotoxic stress. Trends Cardiovasc Med. 2011;21:224-228.
103. Gokhin DS, Lewis RA, McKeown CR, Nowak RB, Kim NE, Littlefield RS, Lieber RL, Fowler VM. Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. J Cell Biol. 2010;189:95-109.
104. Conley CA, Fritz-Six KL, Almenar-Queralt A, Fowler VM. Leiomodins: larger members of the tropomodulin (Tmod) gene family. Genomics. 2001;73:127-139.
105. Dorovkov MV, Beznosoc SN, Shah S, Kotlianskaia L, Kostiukova AS. Effect of mutations imitating the phosphorylation by TRPM7 kinase on the function of the N-terminal domain of tropomodulin. Biofizika. 2008;53:943-949.
106. Runnels LW, Yue L, Clapham DE. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science. 2001;291:1043-1047.
107. Runnels LW, Yue L, Clapham DE. The TRPM7 channel is inactivated by PIP(2) hydrolysis. Nat Cell Biol. 2002;4:329-336.
108. Ashrafian H, McKenna WJ, Watkins H. Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy. Circ Res. 2011;109:86-96.
109. Taegtmeyer H, Sen S, Vela D. Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann N Y Acad Sci. 2010;1188:191-198.
110. Pound KM, Arteaga GM, Fasano M, Wilder T, Fischer SK, Warren CM, Wende AR, Farjah M, Abel ED, Solaro RJ, Lewandowski ED. Expression of slow skeletal TnI in adult mouse hearts confers metabolic protection to ischemia. J Mol Cell Cardiol. 2011;51:236-243.
111. Nixon BR, Thawornkaiwong A, Jin J, Brundage EA, Little SC, Davis JP, Solaro RJ, Biesiadecki BJ. AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function. J Biol Chem. 2012;287:19136-19147.
112. Oliveira SM, Zhang YH, Solis RS, Isackson H, Bellahcene M, Yavari A, Pinter K, Davies JK, Ge Y, Ashrafian H, Walker JW, Carling D, Watkins H, Casadei B, Redwood C. AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes. Circ Res. 2012;110:1192-1201.
113. Sancho Solis R, Ge Y, Walker JW. A preferred AMPK phosphorylation site adjacent to the inhibitory loop of cardiac and skeletal troponin I. Protein Sci. 2011;20:894-907.
114. Horman S, Beauloye C, Vanoverschelde JL, Bertrand L. AMP-activated protein kinase in the control of cardiac metabolism and remodeling. Curr Heart Fail Rep. 2012;9:164-173.
115. Nagendran J, Waller TJ, Dyck JR. AMPK signalling and the control of substrate use in the heart. Mol Cell Endocrinol. 2012
116. Light PE, Wallace CH, Dyck JR. Constitutively active adenosine monophosphate-activated protein kinase regulates voltage-gated sodium channels in ventricular myocytes. Circulation. 2003;107:1962-1965.
117. Nurbaeva MK, Schmid E, Szteyn K, Yang W, Viollet B, Shumilina E, Lang F. Enhanced Ca entry and Na+/Ca exchanger activity in dendritic cells from AMP-activated protein kinase-deficient mice. FASEB J. 2012;26:3049-3058.
118. Ouyang Y, Mamidi R, Jayasundar JJ, Chandra M, Dong WJ. Structural and kinetic effects of PAK3 phosphorylation mimic of cTnI(S151E) on the cTnC-cTnI interaction in the cardiac thin filament. J Mol Biol. 2010;400:1036-1045.
119. Haworth RS, Cuello F, Herron TJ, Franzen G, Kentish JC, Gautel M, Avkiran M. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ Res. 2004;95:1091-1099.
120. Haworth RS, Goss MW, Rozengurt E, Avkiran M. Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor-and protein kinase C-mediated regulation. J Mol Cell Cardiol. 2000;32:1013-1023.
121. + sensitivity and cross-bridge cycling. J Biol Chem. 2010;285:5674-5682.
122. + sensitivity of contraction. J Biol Chem. 2010;285:41686-41700.
123. Dirkx E, Schwenk RW, Coumans WA, Hoebers N, Angin Y, Viollet B, Bonen A, van Eys GJ, Glatz JF, Luiken JJ. Protein kinase D1 is essential for contraction-induced glucose uptake but is not involved in fatty acid uptake into cardiomyocytes. J Biol Chem. 2012;287:5871-5881.